BMO Capital Maintains Outperform on TrueBlue, Maintains $13 Price Target
Portfolio Pulse from Benzinga Newsdesk
BMO Capital analyst Jeffrey Silber maintains an Outperform rating on TrueBlue (NYSE:TBI) with a $13 price target.
June 17, 2024 | 5:08 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BMO Capital analyst Jeffrey Silber has reaffirmed an Outperform rating for TrueBlue (NYSE:TBI) and maintained a price target of $13.
The reaffirmation of an Outperform rating and a maintained price target of $13 by BMO Capital is a positive signal for investors, indicating confidence in TrueBlue's performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100